Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2002
10/16/2002CN1374098A Acne treating Yurong capsule and its production process
10/16/2002CN1374095A Burn treating medicine and its prepn
10/16/2002CN1374080A Prepn and use of composition with cracked disulfide bond
10/16/2002CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/16/2002CN1092517C Method for lowering serum cholesterol levels with 2,6-dialkyl-4-silyl-phenols
10/16/2002CN1092514C Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and ue thereof
10/15/2002US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002US6465647 Oxygen, sulfur and nitrogen substituted cyclohexene and cyclohexane derivatives having retinoid-like biological activity
10/15/2002US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465507 Antitumor agents
10/15/2002US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002US6465471 Cinnamic acid derivatives
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465440 Antimutagenic compositions for treatment and prevention of photodamage to skin
10/15/2002US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002US6465421 Promoting the growth of body and/or head hair and/or combatting the loss of such hair via cyclooxygenase treatment, as well as, contrariwise, retarding and/or preventing the growth of body/cranial hair via lipoxygenase treatment
10/15/2002US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002US6464997 Mutualistic combination of said spirulina platensis powder and fungus selected from the phylum basideomnycota; pesticidal agent
10/15/2002US6464994 Diaper dermatitis preventative medication and a method for making and using same
10/15/2002US6464990 Nanoemulsion based on ethylene oxide and propylene oxide block copolymers and its uses in the cosmetics, dermatological and/or ophthalmological fields
10/15/2002CA2337750C Therapeutic or cosmetic compositions containing dimeric or polymeric forms of hydroxyacids, and their therapeutic use
10/10/2002WO2002079456A2 A method for the preparation of immunologically inert amniotic membranes
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079236A1 Alpha conotoxin peptides with analgesic properties
10/10/2002WO2002079200A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079165A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof
10/10/2002WO2002079157A1 Aryl oxime-piperazines useful as ccr5 antagonists
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078728A2 Peptides for the treatment of wound contracture
10/10/2002WO2002078718A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002WO2002078704A1 Use of cyclopamine in the treatment of psoriasis
10/10/2002WO2002078703A1 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
10/10/2002WO2002078699A1 Compounds and methods
10/10/2002WO2002078697A1 Compounds and methods
10/10/2002WO2002078696A1 Compounds and methods
10/10/2002WO2002078687A2 Delta-aminolevulinic acid for the therapeutical and cosmetic use
10/10/2002WO2002078682A2 Estrogen replacement therapy
10/10/2002WO2002078666A1 Metronidazole pledgets
10/10/2002WO2002078665A1 Encapsulated dyes in cosmetic compositions
10/10/2002WO2002078656A1 Hair-restoring liquid comprising aqueous dispersion of ultrafine titanium particles and process and apparatus for producing the same
10/10/2002WO2002078650A1 Cosmetic emulsion preparation and agent for external use
10/10/2002WO2002078648A2 Topical composition comprising an antifungal
10/10/2002WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002046373A8 Method of collecting placental stem cells
10/10/2002WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2002002051A3 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002WO2001053324A8 Novel haptotactic peptides
10/10/2002US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002US20020147339 5-cyano-2-aminopyrimidine derivatives
10/10/2002US20020147233 Epoxyvibsanin B
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147214 Enzyme inhibitors; anticancer agents
10/10/2002US20020147205 Heterocyclic compounds
10/10/2002US20020147203 Tyrosine kinase inhibitors
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147189 Immunology response; autoimmune disease
10/10/2002US20020147156 Cellular uptake of bioactive agents
10/10/2002US20020147141 Administering caveolin-1 protein
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146678 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
10/10/2002US20020146474 For prophylaxis and therapy of cellulite and localized dermal excess adipose, for treating obesity
10/10/2002US20020146473 High temperature solvent extraction of echinacea plant extracts; drying to form powders, then compressing with excipients to form tablets; efficiency
10/10/2002US20020146466 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/10/2002US20020146439 For therapy of alopecia; cosmetics
10/10/2002US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002US20020146414 Controlled release of non heparin-binding growth factors from heparin-containing matrices
10/10/2002DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002DE10114641A1 Anti-Schuppenmittel Anti-dandruff agents
10/10/2002CA2452152A1 Use of cyclopamine in the treatment of psoriasis
10/10/2002CA2445489A1 Metronidazole pledgets
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2442827A1 "a method for the preparation of immunologically inert amniotic membranes"
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442727A1 Hair-restoring liquid comprising aqueous dispersion of ultrafine titanium particles and process and apparatus for producing the same
10/10/2002CA2442495A1 Alpha conotoxin peptides with analgesic properties
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442481A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
1 ... 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 ... 1065